Christine Cassiano
Chief Corporate Affairs and Brand Strategy Officer
Replay available
Allogene Therapeutics, Inc. (ALLO) Q1 2025 Earnings Call
Allogene Therapeutics, Inc. (NASDAQ: ALLO) Q1 2025 earnings conference call, held 2025-05-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. David Cheng
President and Chief Executive Officer
Dr. Zachary Roberts
Executive Vice President of Research and Development and Chief Medical Officer
Jeff Parker
Chief Financial Officer
Michael Yee
Analyst, Jefferies
Tyler Van Buren
Analyst, TD Cowen
Byron Ahmed
Analyst, Piper Sandler
Brian Chang
Analyst, J.P. Morgan
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Allogene Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.923 Hello, thank you for standing by and welcome to Allergy and Therapeutics first quarter 00:00:04.923 -- 00:00:10.296 2025 conference call. After the speaker's presentation, there will be a question 00:00:10.296 -- 00:00:15.428 and answer session. As a reminder, to ask a question, you need to press star 1-1 on 00:00:15.428 -- 00:00:18.256 your telephone and wait for your name to be announced. 00:00:18.256 -- 00:00:21.319 To withdraw your question, please press star 1-1 again. 00:00:21.319 -- 00:00:24.222 Please be aware that today's conference is being recorded. 00:00:24.222 -- 00:00:29.087 I would now like to turn the call over to Christine Cassiano, Chief Corporate Affairs 00:00:29.087 -- 00:00:34.411 and Brand Strategy Officer. Ms. Cassiano, please go ahead. 00:00:34.713 -- 00:00:38.197 Thank you, Operator, and thanks to all of you for joining this call. 00:00:38.197 -- 00:00:42.121 After the market closed, Allogene issued a press release that provided a business update 00:00:42.121 -- 00:00:45.509 and financial results for the first quarter of 2025. 00:00:45.509 -- 00:00:49.273 This press release and today's webcast are available on our website. 00:00:49.273 -- 00:00:52.336 Following our prepared remarks, we will host a Q&A session. 00:00:52.336 -- 00:00:56.420 We recognize that historically, questions have been multifaceted, but note that we will 00:00:56.420 -- 00:00:59.143 endeavor to keep this call to under an hour. 00:00:59.143 -- 00:01:03.207 I'm joined today by Dr. David Cheng, President and Chief Executive Officer, Dr. 00:01:03.207 -- 00:01:07.411 Zachary Roberts, Executive Vice President of Research and Development and Chief Medical 00:01:07.411 -- 00:01:10.154 Officer, and Jeff Parker, Chief Financial Officer. 00:01:10....